Revolutionary Approach Unveils Gene Activity in Live Brain: Groundbreaking Insights into Neurobiology

Researchers at FutureNeuro, the Research Ireland Centre for Translational Brain Science, and RCSI University of Medicine and Health Sciences have developed a new method to study gene activity in the living human brain. This work, published in JCI Insight, allows for a better understanding of neurological conditions such as epilepsy.

Traditionally, studying gene activity required invasive tissue samples, which is a significant challenge. However, this new approach utilizes molecular traces, like RNA and DNA, collected from electrodes implanted in the brains of epilepsy patients. These electrodes are used clinically to identify seizure activity and now provide a way to link brain activity with gene expression in specific areas.

The study shows that combining molecular data with electrical recordings can deepen our understanding of seizure networks. This advancement may improve the accuracy of epilepsy surgeries, which depend on precise mapping of seizure activity areas.

According to Professor David Henshall, Director of FutureNeuro, this method represents a major leap in epilepsy research. It can detect active genes in patients’ brains, complementing traditional brain imaging and EEG tests, and offering crucial insights for surgical decisions in epilepsy treatment.

Epilepsy impacts around 40,000 people in Ireland, with one in three unable to control seizures with medication. For these patients, surgery is often necessary, and success relies on accurately identifying the regions responsible for seizures.

How could Professor ⁤Henshall’s research impact treatments for neurological disorders beyond epilepsy?

Interview with Professor David​ Henshall, ⁢Director‌ of FutureNeuro

News Directory 3: Professor Henshall, thank you for joining us today. Your team at FutureNeuro has made significant advancements in studying gene ​activity in ⁤the human​ brain. Can you ‌explain the traditional challenges researchers faced in⁣ this area?

Professor⁣ Henshall: Thank you for having me. Traditionally,​ studying ‍gene ⁢activity ​in the brain ⁣required invasive tissue⁣ samples, which posed ethical and ‍practical challenges. Taking tissue samples can be risky and is not always possible, especially in patients with conditions like epilepsy. ⁢This limitation made it difficult to obtain accurate information about gene expression directly linked to brain activity.

News Directory 3: Your team has developed a new method using molecular traces from electrodes implanted in ⁤the ​brains of epilepsy ⁤patients. ​How does this ⁢innovative approach work?

Professor Henshall: Our method takes advantage of the electrodes that are already implanted in patients for clinical monitoring of seizure activity. We collect⁢ RNA and DNA from these electrodes, which allows us to correlate brain electrical activity with gene⁣ expression. This is ⁢a groundbreaking⁣ step forward as it enables us to analyze ⁤gene​ activity in the living brain‌ without the ⁢need for invasive ⁢procedures.

News Directory 3: What are the key findings of ‌your research as published in JCI Insight?

Professor Henshall: We found that by‍ combining molecular data with electrical recordings, we can gain deeper insights into seizure networks. This understanding is critical not only for epilepsy research but also has the potential to enhance‌ the precision of epilepsy surgeries, which rely on identifying the‌ exact areas responsible for‌ seizure activity.

News Directory 3: Can you elaborate on the implications of this research for epilepsy patients in Ireland and beyond?

Professor Henshall: ⁢ Epilepsy affects around 40,000 people in Ireland, ​with a significant number‍ unable to control their seizures with medication. For⁢ these patients, surgery may be the only option. ⁢Our method enhances the ‍surgical​ planning process by ⁤providing more accurate mapping of brain regions involved‌ in seizures, which could lead to better surgical ‍outcomes.

News Directory 3: You mentioned that this research‌ could have ⁣broader applications beyond epilepsy. Could you explain?

Professor Henshall: Yes, indeed. The technique​ we’ve developed could become instrumental in studying other⁢ neurological conditions such as ​Alzheimer’s, Parkinson’s, and schizophrenia. Understanding molecular processes in the living brain opens new avenues for diagnosing and treating​ these disorders, potentially changing the landscape ⁤of how ⁢we approach brain health.

News Directory 3: ‌ Collaboration seems ​to be a significant aspect of this research. How did the international partnerships contribute to the⁣ success of this study?

Professor Henshall: ‌ The collaboration involved a​ talented team, including Professor Vijay Tiwari from the University of Southern⁣ Denmark and various global⁣ partners. This teamwork underscores the importance⁤ of diverse expertise and perspectives in neuroscience research. By ​pooling our resources and knowledge, we were able to accelerate our‌ understanding of brain function at a molecular level.

News Directory 3: what hope do you have for the future of treatment for neurological disorders based on your⁣ findings?

Professor Henshall: I ​am optimistic⁢ that our research will pave the way for more personalized ⁣and effective treatments for epilepsy and potentially ⁤other neurological disorders. ‍By bridging the‌ gap between molecular science and clinical practice, we can enhance our strategies for diagnosis and intervention, ultimately improving the quality of life for those affected by these ​conditions.

News Directory 3: Thank you, Professor Henshall, for​ your insights and for ​pioneering such important work in brain research.

Professor Henshall: ‌ Thank ⁢you for having‌ me. I’m excited about the future and the possibilities our research holds.

Beyond epilepsy, this research has wider implications, opening avenues for studying Alzheimer’s, Parkinson’s, and schizophrenia. Understanding molecular processes in the living brain can significantly aid in addressing these conditions.

The research team, led by Professor Henshall and Professor Vijay Tiwari from the University of Southern Denmark, included global partners from various institutions. This collaboration highlights the importance of international teamwork in advancing our knowledge of brain function at the molecular level. It offers hope for improved diagnosis and treatment for those affected by neurological disorders.

For further details, visit RCSI University of Medicine and Health Sciences or read the study in JCI Insight.